Myollie is a healthcare technology company that develops and commercializes a suite of digital therapeutics for the treatment of chronic diseases.
Myollie's products are designed to empower patients to take control of their health and wellbeing.
The company's flagship product is a digital therapeutic for the management of type 2 diabetes.